☰

Ryan M. Zurakowski, Ph.D. - Publications

Affiliations: 
2004 University of California, Santa Barbara, Santa Barbara, CA, United States 
Area:
Control Systems
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Paryad-Zanjani S, Jagarapu A, Piovoso MJ, Zurakowski R. Ongoing HIV replication in lymph node sanctuary sites in treated individuals contributes to the total latent HIV at a very slow rate. Journal of Theoretical Biology. 575: 111651. PMID 37898364 DOI: 10.1016/j.jtbi.2023.111651  0.436
2023 Paryad-Zanjani S, Jagarapu A, Piovoso MJ, Zurakowski R. Ongoing HIV replication in lymph node sanctuary sites in treated patients contributes to the total latent HIV at a very slow rate. Biorxiv : the Preprint Server For Biology. PMID 36909554 DOI: 10.1101/2023.02.18.529086  0.418
2021 Pinzone MR, Weissman S, Pasternak AO, Zurakowski R, Migueles S, O'Doherty U. Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication. Jci Insight. PMID 34228640 DOI: 10.1172/jci.insight.150794  0.393
2021 Cortes LM, Zurakowski R. Resistance evolution in HIV - modeling when to intervene. Proceedings of the ... American Control Conference. American Control Conference. 2012: 4053-4058. PMID 25264400 DOI: 10.1109/ACC.2012.6315693  0.344
2021 Luo R, Piovoso MJ, Zurakowski R. Modeling-error robustness of a viral-load preconditioning strategy for HIV treatment switching. Proceedings of the ... American Control Conference. American Control Conference. 2010: 5155-5160. PMID 24954972 DOI: 10.1109/acc.2010.5530483  0.332
2021 Zurakowski R, Churgin M, Perez C, Rodriguez M. Approximate-model closed-loop minimal sampling method for HIV viral-load minima detection. Proceedings of the ... American Control Conference. American Control Conference. 5418-5419. PMID 23001383 DOI: 10.1109/acc.2011.5991281  0.411
2020 Venanzi Rullo E, Pinzone MR, Cannon L, Weissman S, Ceccarelli M, Zurakowski R, Nunnari G, O'Doherty U. Persistence of an intact HIV reservoir in phenotypically naive T cells. Jci Insight. 5. PMID 33055422 DOI: 10.1172/jci.insight.133157  0.385
2020 Jagarapu A, Piovoso MJ, Zurakowski R. Optimal control modulation of HIV reservoir formation rate by antigen infusion. Proceedings of the ... Ieee Conference On Decision & Control. Ieee Conference On Decision & Control. 2019: 5662-5667. PMID 32874015 DOI: 10.1109/cdc40024.2019.9028891  0.527
2020 Shirazi J, Donzanti MJ, Nelson KM, Zurakowski R, Fromen CA, Gleghorn JP. Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression. Cellular and Molecular Bioengineering. 1-26. PMID 32837585 DOI: 10.1007/S12195-020-00637-W  0.593
2020 Jagarapu A, Piovoso MJ, Zurakowski R. An Integrated Spatial Dynamics-Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes. Frontiers in Bioengineering and Biotechnology. 8: 667. PMID 32676500 DOI: 10.3389/Fbioe.2020.00667  0.409
2020 Pinzone MR, Bertuccio MP, VanBelzen DJ, Zurakowski R, O'Doherty U. Next Generation Sequencing in a direct model of HIV infection reveals important parallels and differences to reservoir dynamics. Journal of Virology. PMID 32051279 DOI: 10.1128/JVI.01900-19  0.45
2019 Jagarapu A, Mann R, Piovoso MJ, Zurakowski R. Positive feedback through inflammation creates bistable behavior in HIV tissue sanctuaries. Proceedings of the ... American Control Conference. American Control Conference. 2019: 3456-3461. PMID 32148339 DOI: 10.23919/acc.2019.8815245  0.499
2018 Cannon L, Vargas-Garcia CA, Jagarapu A, Piovoso MJ, Zurakowski R. HIV 2-LTR experiment design optimization. Plos One. 13: e0206700. PMID 30408070 DOI: 10.1371/Journal.Pone.0206700  0.682
2018 Vargas-Garcia C, Zurakowski R, Singh A. Synaptic transmission may provide an evolutionary benefit to HIV through modulation of latency. Journal of Theoretical Biology. PMID 30048721 DOI: 10.1016/J.Jtbi.2018.07.030  0.717
2018 Martinez-Picado J, Zurakowski R, Buzón MJ, Stevenson M. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence. Retrovirology. 15: 15. PMID 29378611 DOI: 10.1186/S12977-018-0398-1  0.585
2017 Cannon L, Jagarapu A, Vargas-Garcia CA, Piovoso MJ, Zurakowski R. Implications of Measurement Assay Type in Design of HIV Experiments. Proceedings of the ... Ieee Conference On Decision & Control. Ieee Conference On Decision & Control. 2017: 4106-4111. PMID 29445252 DOI: 10.1109/CDC.2017.8264262  0.714
2017 Jagarapu A, Cannon L, Zurakowski R. Experiment Design for Early Molecular Events in HIV Infection. Proceedings of the ... American Control Conference. American Control Conference. 2017: 122-127. PMID 29332992 DOI: 10.23919/ACC.2017.7962941  0.516
2016 Cannon L, Garcia CAV, Piovoso MJ, Zurakowski R. Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence. Proceedings of the ... American Control Conference. American Control Conference. 2016: 1295-1300. PMID 29332991 DOI: 10.1109/ACC.2016.7525096  0.344
2016 Cardozo EF, Piovoso MJ, Zurakowski R. Increased inflammation in sanctuary sites may explain viral blips in HIV infection. Iet Systems Biology. 10: 153-166. PMID 27444025 DOI: 10.1049/Iet-Syb.2015.0066  0.517
2015 Zurakowski R. Using the Tools we Have: Low-efficacy Vaccines and HIV Ebiomedicine. 2: 1867-1868. PMID 26844264 DOI: 10.1016/J.Ebiom.2015.12.007  0.355
2014 Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, et al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. Journal of Virology. 88: 10056-65. PMID 24965451 DOI: 10.1128/Jvi.01046-14  0.574
2014 Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, et al. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nature Medicine. 20: 139-42. PMID 24412925 DOI: 10.1038/Nm.3445  0.486
2014 Cardozo EF, Luo R, Piovoso MJ, Zurakowski R. Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification. Journal of Theoretical Biology. 345: 61-9. PMID 24378646 DOI: 10.1016/J.Jtbi.2013.12.020  0.49
2014 Vargas-Garcia CA, Cannon L, Singh A, Zurakowski R. Optimal multi-drug approaches for reduction of the latent pool in HIV Ifac Proceedings Volumes (Ifac-Papersonline). 19: 784-789. DOI: 10.3182/20140824-6-Za-1003.02720  0.722
2013 Luo R, Cardozo EF, Piovoso MJ, Wu H, Buzon MJ, Martinez-Picado J, Zurakowski R. Modelling HIV-1 2-LTR dynamics following raltegravir intensification. Journal of the Royal Society, Interface / the Royal Society. 10: 20130186. PMID 23658114 DOI: 10.1098/Rsif.2013.0186  0.565
2012 Luo R, Piovoso MJ, Zurakowski R. Modeling Uncertainty in Single-Copy Assays for HIV Journal of Clinical Microbiology. 50: 3381-3382. PMID 22837324 DOI: 10.1128/Jcm.01254-12  0.514
2012 Luo R, Piovoso MJ, Martinez-Picado J, Zurakowski R. HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics. Plos One. 7. PMID 22815727 DOI: 10.1371/Journal.Pone.0040198  0.46
2012 Cardozo EF, Zurakowski R. Robust Closed-Loop Minimal Sampling Method for HIV Therapy Switching Strategies Ieee Transactions On Biomedical Engineering. 59: 2227-2234. PMID 22652153 DOI: 10.1109/Tbme.2012.2201479  0.402
2012 Luo R, Piovoso MJ, Zurakowski R. Quantitative analysis of viral persistence and transient viral load rebound from HIV clinical data. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2011: 3585-8. PMID 22255114 DOI: 10.1109/IEMBS.2011.6090599  0.439
2012 Cardozo EF, Zurakowski R. Measurement error robustness of a closed-loop minimal sampling method for HIV therapy switching. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2011: 116-9. PMID 22254264 DOI: 10.1109/IEMBS.2011.6089910  0.324
2011 Luo R, Piovoso MJ, Martinez-Picado J, Zurakowski R. Optimal antiviral switching to minimize resistance risk in HIV therapy. Plos One. 6. PMID 22073250 DOI: 10.1371/Journal.Pone.0027047  0.488
2011 Zurakowski R. Nonlinear observer output-feedback MPC treatment scheduling for HIV Biomedical Engineering Online. 10: 40-40. PMID 21619634 DOI: 10.1186/1475-925X-10-40  0.585
2011 Luo R, Cannon L, Hernandez J, Piovoso MJ, Zurakowski R. Controlling the Evolution of Resistance. Journal of Process Control. 21: 367-378. PMID 21516198 DOI: 10.1016/J.Jprocont.2010.11.010  0.403
2008 Luo R, Zurakowski R. Resistance Risk Management in HIV Therapy Switching with Explicit Quiescent T-Cell Modeling Ifac Proceedings Volumes. 41: 10325-10330. DOI: 10.3182/20080706-5-Kr-1001.01747  0.486
2007 Zurakowski R, Wodarz D. Model-driven Approaches for in Vitro Combination Therapy using ONYX-015 Replicating Oncolytic Adenovirus Journal of Theoretical Biology. 245: 1-8. PMID 17095020 DOI: 10.1016/J.Jtbi.2006.09.029  0.419
2006 Zurakowski R, Teel AR. A model predictive control based scheduling method for HIV therapy. Journal of Theoretical Biology. 238: 368-82. PMID 15993900 DOI: 10.1016/J.Jtbi.2005.05.004  0.671
2005 Zurakowski R, Messina MJ, Tuna SE, Teel AR. Treatment scheduling for HIV using robust nonlinear model predictive control Australian Journal of Electrical and Electronics Engineering. 2: 49-58. DOI: 10.1080/1448837X.2005.11464114  0.714
Show low-probability matches.